| Robert Douglas Bostick Iii, MD | |
|
3001 Division St Ste 204, Metairie, LA 70002 | |
| (504) 541-5800 | |
| (504) 541-5801 |
| Full Name | Robert Douglas Bostick Iii |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 28 Years |
| Location | 3001 Division St Ste 204, Metairie, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518916915 | NPI | - | NPPES |
| 1483192 | Medicaid | LA | |
| 200045552 | Other | LA | RR MEDICARE INDIVIDUAL |
| 1792217 | Other | LA | MEDICAID GROUP |
| CK4990 | Other | LA | RAILROAD MEDICARE GROUP |
| 5B353 | Other | LA | MEDICARE GROUP |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 023026 (Louisiana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Metairie Orthopedics And Sports Medicine | 6406189869 | 3 |
News Archive
CMAJ will publish a ground-breaking series of comprehensive new guidelines on immigrant health (pre-embargo link only) beginning June 7, 2010 . The Canadian Immigrant Health Guidelines, a multi-part series, will assist clinicians, policy makers and immigrants in understanding the diverse needs of immigrants to Canada. Few resources like this exist in the international medical literature.
Tolero Pharmaceuticals, Inc., a clinical-stage company developing treatments for serious hematological diseases, today announced that the U.S. Food and Drug Administration has granted Orphan Drug designation for Alvocidib for the treatment of patients with acute myeloid leukemia (AML).
The substantial increase in the use of medical imaging during recent years has fueled speculation that imaging costs were a major factor behind the rise in overall health care costs.
Bioengineering - the application of engineering principles to understand and treat medical conditions - is delivering innovative solutions for diagnosing and repairing damage to the brain caused by a traumatic injury.
› Verified 7 days ago
| Entity Name | Metairie Orthopedics & Sports Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184288128 PECOS PAC ID: 6406189869 Enrollment ID: O20190618000520 |
News Archive
CMAJ will publish a ground-breaking series of comprehensive new guidelines on immigrant health (pre-embargo link only) beginning June 7, 2010 . The Canadian Immigrant Health Guidelines, a multi-part series, will assist clinicians, policy makers and immigrants in understanding the diverse needs of immigrants to Canada. Few resources like this exist in the international medical literature.
Tolero Pharmaceuticals, Inc., a clinical-stage company developing treatments for serious hematological diseases, today announced that the U.S. Food and Drug Administration has granted Orphan Drug designation for Alvocidib for the treatment of patients with acute myeloid leukemia (AML).
The substantial increase in the use of medical imaging during recent years has fueled speculation that imaging costs were a major factor behind the rise in overall health care costs.
Bioengineering - the application of engineering principles to understand and treat medical conditions - is delivering innovative solutions for diagnosing and repairing damage to the brain caused by a traumatic injury.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert Douglas Bostick Iii, MD 3001 Division St Ste 204, Metairie, LA 70002-5855 Ph: (504) 541-5800 | Robert Douglas Bostick Iii, MD 3001 Division St Ste 204, Metairie, LA 70002 Ph: (504) 541-5800 |
News Archive
CMAJ will publish a ground-breaking series of comprehensive new guidelines on immigrant health (pre-embargo link only) beginning June 7, 2010 . The Canadian Immigrant Health Guidelines, a multi-part series, will assist clinicians, policy makers and immigrants in understanding the diverse needs of immigrants to Canada. Few resources like this exist in the international medical literature.
Tolero Pharmaceuticals, Inc., a clinical-stage company developing treatments for serious hematological diseases, today announced that the U.S. Food and Drug Administration has granted Orphan Drug designation for Alvocidib for the treatment of patients with acute myeloid leukemia (AML).
The substantial increase in the use of medical imaging during recent years has fueled speculation that imaging costs were a major factor behind the rise in overall health care costs.
Bioengineering - the application of engineering principles to understand and treat medical conditions - is delivering innovative solutions for diagnosing and repairing damage to the brain caused by a traumatic injury.
› Verified 7 days ago
Dr. David W. Aiken, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4224 Houma Blvd, Suite 650, Metairie, LA 70006 Phone: 504-456-5152 Fax: 504-456-5019 | |
Dr. Warren Roger Bourgeois Iii, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3939 Houma Blvd, Suite 18, Metairie, LA 70006 Phone: 504-455-0093 Fax: 504-454-3964 | |
Dr. Matko Milicic, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 312 Friedrichs Ave, Metairie, LA 70005 Phone: 504-832-5940 | |
John G Burvant, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3939 Houma Blvd, Suite 21, Metairie, LA 70006 Phone: 504-885-6464 Fax: 504-885-6414 | |
Russell Levy, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 4905 Folse Dr, Metairie, LA 70006 Phone: 504-455-4883 | |
Ryan Charles Roubion, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3001 Division St Ste 204, Metairie, LA 70002 Phone: 504-541-5800 Fax: 504-541-5801 | |
Dr. Bobby L Mimeles, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 4720 S I 10 Service Rd W, Suite 301, Metairie, LA 70001 Phone: 504-885-8225 Fax: 504-885-7642 |